Earlier this month, the Memorial Sloan Kettering Cancer Center announced that it would be receiving a landmark $100 million gift from philanthropist and private equity mogul Henry Kravis and his wife Marie-Josée. The Marie-Josée and Henry R. Kravis Foundation is happy to support a groundbreaking approach to precision oncology, explains the Sloan Kettering Cancer Center. Because of their immense generosity, which makes the advancement of cancer research and treatment possible, the new Marie-Josée and Henry R. Kravis Center for Molecular Oncology is named in their honor.
Forbes provides the inside scoop:“Kravis – the founder of buyout shop KKR who has a net worth of just under $5 billion – and his wife, chair of the Sloan Kettering Institute and a member of Sloan Kettering’s board of overseers since 2000, were prompted to make the gift after discussing with Sloan Kettering officials the emerging benefits of analyzing patients’ DNA and tailoring treatments to the specific characteristics of individuals tumors.”
The new Marie-Josée and Henry R. Kravis Center for Molecular Oncology embodies an innovative program that will reshape clinical trials completely. “Memorial Sloan Kettering has already proven itself to be a leader in understanding cancer at the genetic level and in putting that knowledge to work for patients,” explains Henry Kravis, who says that his donation will help take the Cancer Center’s impressive work to new levels. Without the massive donation from the Kravises and their foundation, such progress might not have been possible.
Henry Kravis recently told the Wall Street Journal, “I like to do things that are transformative and more importantly make a difference,” of his commitment to improving the lives of others through medicine, technology, and education. The massive $100 million donation will be disbursed over several years, but the work the new Molecular Oncology center is striving to accomplish is beginning right now.
For more information, be sure to read the most recent press release from the Memorial Sloan Kettering Cancer Center.